en · de · es · pt
peptide-index.peptides6908.com › Info › Analytical Characterization And Stability — Reference Sheet

Analytical Characterization And Stability — Reference Sheet

By Editorial Desk · published 2026-01-31 · last reviewed 2026-03-09 · Info

Everything below concerns Allergen assay. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.

Updated 2026-03-09. Numbers and descriptions here follow the published literature rather than marketing material.

Analytical Characterization and Stability

Hydrolysate powders are hygroscopic and can absorb moisture during storage, which may promote caking, browning, and loss of solubility. Cool, dry conditions and sealed packaging slow these changes, while high humidity and warm temperatures accelerate Maillard reactions between peptides and residual sugars. Liquid hydrolysates are more perishable and often require refrigeration or preservatives. Shelf-life studies usually monitor moisture, color, solubility, free amino groups, and microbial load over time. Stability depends on residual lactose, water activity, packaging barrier properties, and the initial peptide profile.

Degree of hydrolysis is commonly estimated by titrating liberated carboxyl groups, measuring soluble nitrogen in trichloroacetic acid, or using o-phthaldialdehyde assays. Molecular weight distribution is often examined by size-exclusion chromatography, sodium dodecyl sulfate polyacrylamide gel electrophoresis, or mass spectrometry. These methods answer different questions: titration estimates bond cleavage, while chromatography describes peptide size ranges. Because no single reference method is universally applied, values reported by different laboratories may not be directly comparable. Method details such as calibration standards and sample preparation strongly influence results.

Routine quality control for hydrolysate powders includes total nitrogen or protein content by Kjeldahl or Dumas combustion, moisture by oven or Karl Fischer titration, ash, and mineral profiles. Microbiological tests typically cover total aerobic counts, yeasts, molds, and specified pathogens according to regional food safety rules. Amino acid analysis can quantify free amino acids and peptide-bound residues after hydrolysis. For products intended for special populations, additional tests may target residual lactose, fat, or specific allergenic proteins. Specifications are set by the manufacturer and may exceed general food-grade requirements.

Background and Production of Whey Hydrolysate

Whey protein hydrolysate appears in foods, infant formula, sports nutrition, and specialized clinical nutrition. Its production can reduce viscosity and improve heat stability compared with intact whey protein. Bitterness is common because short hydrophobic peptides can activate bitter taste receptors. The ingredient is not the same as free amino acids; it remains a mixture of peptides of different lengths. Composition varies by supplier, enzyme, and process, so two hydrolysates with the same protein content may behave differently in a formulation.

Whey protein hydrolysate is a dairy ingredient made by treating whey protein with enzymes or, less often, acid or heat to break peptide bonds. The starting material is typically sweet whey or acid whey from cheese making, first concentrated and dried into whey protein concentrate or isolate. Hydrolysis shortens long protein chains into smaller peptides, changing functional properties such as solubility, viscosity, and foam formation. The resulting powder contains peptides, residual intact protein, moisture, minerals, and variable amounts of lactose and fat depending on the starting material.

Enzymatic hydrolysis usually uses proteases from microbial, plant, or animal sources. The enzyme choice, pH, temperature, and reaction time determine which peptide bonds are cleaved and the final peptide profile. After hydrolysis, the enzyme is inactivated by heat, and the mixture is clarified, filtered, concentrated, and spray-dried. Manufacturers may use ultrafiltration to remove larger peptides or minerals. The degree of hydrolysis, often reported as a percentage, describes the proportion of peptide bonds broken. A higher degree generally means shorter peptides, but it does not by itself define taste, allergenicity, or biological activity.

Whey-protein-hydrolysate at a glance

PropertyValueNotes
Moisture contentTypically below 6%Higher moisture increases caking, browning, and microbial risk.
Water activityOften below 0.6Low water activity limits microbial growth in dry powders.
Typical storage temperature15–25 °CKeep sealed, dry, and away from strong odors and direct light.
Protein quantificationKjeldahl or Dumas combustionMeasures total nitrogen; a conversion factor estimates protein.
Peptide size analysisSize-exclusion chromatography or mass spectrometryResults depend on method, calibration, and sample preparation.

Production and Quality Control

Hydrolysates are generally stable as dry powders but can absorb moisture and undergo browning during warm storage. The bitter taste of some hydrolysates arises from hydrophobic peptides exposed by cleavage, and it varies with enzyme choice and degree of hydrolysis. Reduced allergenicity is sometimes claimed, but residual IgE-binding peptides may remain, especially in partial hydrolysates. Regulatory frameworks treat extensively hydrolyzed and partially hydrolyzed products differently, and labeling rules vary by country. More research is needed on how specific peptide profiles relate to clinical outcomes.

Commercial production begins with whey protein concentrate or isolate dissolved in water. A protease is added under controlled pH and temperature, and the reaction is stopped by heat or pH adjustment once a target degree of hydrolysis is reached. Membrane filtration, often ultrafiltration or diafiltration, removes enzymes and small solutes while retaining peptides. The liquid is then concentrated and spray-dried into a powder. Each step influences peptide length, mineral content, and flavor.

Quality control focuses on degree of hydrolysis, molecular weight distribution, protein content, moisture, ash, and microbial limits. Degree of hydrolysis is commonly calculated from the number of cleaved peptide bonds relative to total peptide bonds. Size-exclusion chromatography and mass spectrometry can describe peptide size ranges, while amino acid analysis quantifies composition. Standard methods from dairy science organizations are often used, though no single method captures every functional property. Results are therefore reported alongside processing conditions.

Related pages on this site

Composition And Production Basics

Hydrolysates usually contain 70% to 90% protein on a dry basis, with variable ash, fat, and carbohydrate. Solubility in water is generally high over a broad pH range, though bitter notes can appear from exposed hydrophobic peptides. The powder tends to absorb moisture and may brown during prolonged warm storage. Applications span sports nutrition, clinical nutrition, infant formulas, and flavor systems. Regulatory status and labeling rules differ by country. A key open question is whether a given peptide profile reliably predicts functional or sensory behavior across different food matrices.

Whey protein hydrolysate is a dairy ingredient made by breaking peptide bonds in whey proteins. Enzymes such as proteases, or in some processes acid or heat, cleave the protein chains into shorter peptides and free amino acids. The starting material may be sweet whey, acid whey, whey protein concentrate, or whey protein isolate. Because raw materials and reaction conditions differ, the final mixture is not a single uniform substance. Its peptide profile, mineral content, and residual lactose depend on the source and the processing steps used.

Production typically begins with pasteurization and concentration of whey. A protease is added under controlled temperature and pH, and the reaction is stopped by heat or pH change when the target extent of cleavage is reached. Ultrafiltration or diafiltration may remove enzymes, salts, and small molecules. The liquid is then spray dried into a powder. Process parameters shape bitterness, solubility, and peptide size. Established control points include enzyme type, reaction time, and inactivation conditions. How these variables interact across large-scale batches remains an area of active process development.

Analytical Testing and Quality Control

Physical properties such as particle size, bulk density, and reconstitution behavior affect handling and finished product quality. Water activity and moisture content influence shelf life; high moisture can promote caking, browning, and microbial growth. Color is monitored because Maillard reactions between peptides and reducing sugars can darken the powder during storage. Taste panels and instrumental methods may assess bitterness, which is a common challenge for hydrolysates. Specifications often include limits for heavy metals, microbiological counts, and residual fat, depending on the intended market.

Quality control for hydrolyzed whey protein focuses on composition, peptide size, and batch consistency. Protein content is commonly measured by Kjeldahl or combustion analysis, while moisture and ash are determined by gravimetric methods. Peptide molecular weight distribution is often assessed by size exclusion chromatography or mass spectrometry. The extent of hydrolysis can be estimated by titration, trinitrobenzenesulfonic acid assays, or formol titration. Because hydrolysis produces a complex mixture, no single test captures every relevant property, and laboratories often combine several methods.

Allergen testing is relevant because whey is a milk-derived ingredient. Immunoassays can detect residual milk proteins, but hydrolysis may alter or destroy antibody-binding sites, leading to false negatives or underestimation. Liquid chromatography with tandem mass spectrometry can identify specific peptide markers and is less dependent on intact protein epitopes. Regulatory labeling rules for milk allergens vary by country, and a product described as hydrolyzed is not automatically exempt from allergen declaration. For infants, specialized formulas require strict control of protein molecular weight and sterility, which adds testing beyond routine composition.

Composition and Production Overview

Composition reflects the whey source and the extent of hydrolysis. Beta-lactoglobulin and alpha-lactalbumin fragments are common, and sweet whey may contribute glycomacropeptide. The amino acid profile remains broadly similar to intact whey protein, but peptide size affects how quickly nitrogen appears in blood after ingestion. Bitter notes often arise from short peptides with hydrophobic residues. Hydrolysates are used in sports nutrition, infant formula, and clinical nutrition, though effects on muscle, immunity, or allergy risk are separate research questions rather than guaranteed properties.

Whey protein hydrolysate is derived from whey, the liquid byproduct of cheese-making or casein coagulation. It consists of peptides and free amino acids produced when peptide bonds are cleaved by enzymes or acid. Hydrolysis lowers the average molecular weight and can change solubility, viscosity, and bitterness. The degree of hydrolysis indicates the proportion of peptide bonds broken and distinguishes partial from extensive hydrolysates. Commercial ingredients vary widely in peptide size, mineral content, and lactose level.

Production usually starts with whey protein concentrate or isolate. The material is dissolved, pasteurized, and adjusted to conditions that favor a chosen protease, such as trypsin, pepsin, or papain. Enzyme choice, pH, temperature, and reaction time determine peptide length, terminal residues, and functional behavior. After hydrolysis, the enzyme is inactivated by heat or pH change, and the liquid is clarified, filtered, concentrated, and dried. Membrane filtration can further fractionate peptides and remove some minerals or lactose. The final powder is typically spray-dried.

Notes from published material

==== Australia ==== 2C-B is controlled in Australia and on the list of substances subject to import and export controls (Appendix B). It was placed on Schedule One of the Drugs Misuse and Trafficking Act when it first came to notice in 1994, when in a showcase legal battle chemist R. Simpson was charged with manufacturing the substance in Sydney. Alexander Shulgin came to Australia to testify on behalf of the defense, to no avail. 2C-B is not specifically listed in the Australia Poisons Standard (October 2015), however similar drugs such as 2C-T-2 and 2C-I are making 2C-B fall under the Australian analogue act.

Bont possesses no superhuman abilities, but he occasionally used Mutant Growth Hormone, a substance that temporarily enhanced his speed and strength and caused his eyes to emit a green glow. Sigourney Weaver portrays a female version of Alexander Bont, primarily known as Alexandra, in The Defenders. This version is the leader of the Hand. Alexandra is described as an "adversary" rather than a villain and was intended to be portrayed sympathically as a supporting character in Elektra Natchios' story. Alexandra is one of the five "fingers" of the Hand, who all gained immortality using the healing powers of qi. Following the death of Elektra, Alexandra resurrects her to create the ancient weapon Black Sky, which is prophesied to destroy all enemies of the Hand. Alexandra intends to use Elektra to steal the Iron Fist from Danny Rand. However, Elektra regains her memories of her previous life and kills Alexandra, claiming leadership of the Hand. http://www.marvunapp.com/Appendix4/bontalexander.htm http://www.imdb.com/title/tt1784594/

Lead (82Pb) has four observationally stable isotopes: 204Pb, 206Pb, 207Pb, 208Pb. Lead-204 is entirely a primordial nuclide and is not a radiogenic nuclide. The three isotopes lead-206, lead-207, and lead-208 represent the ends of three decay chains: the uranium series (or radium series), the actinium series, and the thorium series, respectively; a fourth decay chain, the neptunium series, terminates with the thallium isotope 205Tl. The three series terminating in lead represent the decay chain products of long-lived primordial 238U, 235U, and 232Th. Each isotope also occurs, to some extent, as primordial isotopes that were made in supernovae, rather than radiogenically as daughter products. The fixed ratio of lead-204 to the primordial amounts of the other lead isotopes may be used as the baseline to estimate the extra amounts of radiogenic lead present in rocks as a result of decay from uranium and thorium. This is the basis for lead–lead dating and uranium–lead dating. The longest-lived radioisotopes, both decaying by electron capture, are 205Pb with a half-life of 17.0 million years and 202Pb with a half-life of 52,500 years. A shorter-lived naturally occurring radioisotope, 210Pb with a half-life of 22.2 years, is useful for studying the sedimentation chronology of environmental samples on time scales shorter than 100 years. The heaviest stable isotope, 208Pb, belongs to this element. (The more massive 209Bi, long considered to be stable, actually has a half-life of 2.01×1019 years.) 208Pb is also a doubly magic isotope, as it has 82 protons and 126 neutrons.

Low birth weight newborns might also be the result of hypoglycemia, especially in patients with type 1 diabetes, because they are frequently more insulin sensitive than persons with type 2 diabetes and more likely to be unaware of their hypoglycemic state. Close glucose monitoring is essential because after 16 weeks of pregnancy, women with preexisting diabetes become more insulin resistant and their insulin demands may fluctuate weekly. The need for insulin may rise from one pregnancy to the next. Therefore, it is realistic to expect higher needs for glucose control with subsequent pregnancies in multiparous women.

=== Cytotoxicity and anticancer potential === Snake venom LAAOs exhibit selective cytotoxicity, preferentially inducing cell death in cancerous cells while sparing normal ones. This effect is largely mediated by hydrogen peroxide generated during enzymatic catalysis, which induces mitochondrial depolarization, DNA fragmentation, and apoptosis. LAAOs from various snake species, including Bothrops atrox and Cerastes cerastes, have shown potent activity against melanoma, breast, and neuronal cancer cells in vitro, with EC50 values in the low micromolar range. The enzyme's selectivity and ability to modulate apoptotic pathways suggest promising applications in anticancer drug development.

Sources: en.wikipedia.org

Further detail

The Mustang was initially developed for the RAF, which was its first user. As the first Mustangs were built to British requirements, these aircraft used factory numbers and were not P-51s; the order comprised 320 NA-73s, followed by 300 NA-83s, all of which were designated Mustang Mark I by the RAF. The first RAF Mustangs supplied under Lend-Lease were 93 Mk Ia designated as P-51s by the USAAF, followed by 50 P-51As used as Mustang Mk IIs. Aircraft supplied to Britain under Lend-Lease were required for accounting purposes to be on the USAAC's books before they could be supplied to Britain, but the British Aircraft Purchasing Commission signed its first contract for the North American NA-73 on 24 April 1940, before Lend-Lease was in effect. After the arrival of the initial aircraft in the UK in October 1941, the first squadron of Mustang Mk Is entered service in January 1942, the first being No. 26 Squadron RAF. Due to poor high-altitude performance, the Mustangs were used by Army Co-operation Command, rather than Fighter Command, and were used for tactical reconnaissance and ground-attack duties. On 10 May 1942, Mustangs first flew over France, near Berck-sur-Mer. On 27 July 1942, 16 RAF Mustangs undertook their first long-range reconnaissance mission over Germany. During the amphibious Dieppe Raid on the French coast (19 August 1942), four British and Canadian Mustang squadrons, including 26 Squadron, saw action covering the assault on the ground. By 1943–1944, British Mustangs were used extensively to seek out V-1 flying bomb sites.

==== MeSH D12.125.166 – amino acids, sulfur ==== MeSH D12.125.166.175 – cystathionine MeSH D12.125.166.215 – cysteic acid MeSH D12.125.166.230 – cysteine MeSH D12.125.166.230.259 – acetylcysteine MeSH D12.125.166.230.310 – carbocysteine MeSH D12.125.166.230.330 – cysteinyldopa MeSH D12.125.166.230.369 – cystine MeSH D12.125.166.230.700 – selenocysteine MeSH D12.125.166.388 – ethionine MeSH D12.125.166.498 – homocysteine MeSH D12.125.166.498.050 – s-adenosylhomocysteine MeSH D12.125.166.554 – homocystine MeSH D12.125.166.676 – methionine MeSH D12.125.166.676.180 – s-adenosylmethionine MeSH D12.125.166.676.450 – n-formylmethionine MeSH D12.125.166.676.450.440 – n-formylmethionine leucyl-phenylalanine MeSH D12.125.166.676.620 – methionine sulfoximine MeSH D12.125.166.676.620.125 – buthionine sulfoximine MeSH D12.125.166.676.900 – selenomethionine MeSH D12.125.166.676.950 – vitamin u MeSH D12.125.166.786 – penicillamine MeSH D12.125.166.786.500 – s-nitroso-n-acetylpenicillamine MeSH D12.125.166.800 – thiopronine MeSH D12.125.166.893 – thiorphan

== Awards and recognitions == Rex has been named one of the top 100 hospitals in the country by Thomson (2008) and named one of the Best Places to Work in Healthcare by Modern Healthcare (2008). In 2014, Rex was recognized as the hospital with the best patient interactions in the state of North Carolina. In a study done by an independent company, Axial Exchange, Rex was ranked highest based on readmissions, patient satisfaction, and self care tools and education. In 2010, it was named a Bariatric Center of Excellence by the American Society for Bariatric Surgery. Rex was the first hospital in the Triangle, and one of only 10 in North Carolina to receive Magnet Recognition, which places Rex nurses among the top two percent in the country.

In many histological preparations of the submandibular gland, the serous acinar cells located in the hybrid seromucous acini are pushed out from between the mucous acinar cells, and appear as crescent-shaped demilunes located at the back of the acini. This fixation artifact can be avoided by rapid-freezing fixation.

Eculizumab (Soliris) appears to be useful for atypical hemolytic uremic syndrome (aHUS). In September 2011 the U.S. Food and Drug Administration (FDA) approved it as an orphan drug to treat people with aHUS. This approval was based on two small prospective trials of 17 people and 20 people. In the UK, NICE issued guidance on the use of Eculizumab for treating aHUS, based on five evidence sources, including those used by the FDA No randomised controlled trials were identified. All prospective studies were phase 2, open‑label, non‑randomised, single‑arm studies that included patients with different clinical baseline characteristics. The prospective studies lasted 26 weeks; however, patients were allowed to continue treatment with eculizumab in a long‑term extension study. Ravulizumab-cwvz (Ultomiris) is a second generation monoclonal antibody for aHUS made by Alexion pharmaceuticals, Inc. The target of ravulizumab-cwvz is the same eculizumab (Soliris) with changes to the structure of the antibody resulting in a longer serum half life and therefore reduced dosing regimen.

Sources: en.wikipedia.org

Background from the literature

{\displaystyle {\begin{array}{l}{}\\{\ce {^{235}_{92}U->[\alpha ][7.04\times 10^{8}\ {\ce {y}}]{^{231}_{90}Th}->[\beta ^{-}][25.52\ {\ce {h}}]{^{231}_{91}Pa}->[\alpha ][3.27\times 10^{4}\ {\ce {y}}]{^{227}_{89}Ac}}}{\begin{Bmatrix}{\ce {->[98.62\%\beta ^{-}][21.772\ {\ce {y}}]{^{227}_{90}Th}->[\alpha ][18.693\ {\ce {d}}]}}\\{\ce {->[1.38\%\alpha ][21.772\ {\ce {y}}]{^{223}_{87}Fr}->[\beta ^{-}][22.00\ {\ce {min}}]}}\end{Bmatrix}}{\ce {^{223}_{88}Ra->[\alpha ][11.435\ {\ce {d}}]{^{219}_{86}Rn}}}\\{\ce {^{219}_{86}Rn->[\alpha ][3.96\ {\ce {s}}]{^{215}_{84}Po}->[\alpha ][1.781\ {\ce {ms}}]{^{211}_{82}Pb}->[\beta ^{-}][36.16\ {\ce {min}}]{^{211}_{83}Bi}}}{\begin{Bmatrix}{\ce {->[99.724\%\alpha ][2.14\ {\ce {min}}]{^{207}_{81}Tl}->[\beta ^{-}][4.77\ {\ce {min}}]}}\\{\ce {->[0.276\%\beta ^{-}][2.14\ {\ce {min}}]{^{211}_{84}Po}->[\alpha ][0.516\ {\ce {s}}]}}\end{Bmatrix}}{\ce {^{207}_{82}Pb}}\end{array}}}

In 2015 researchers demonstrated a small 600 mAh capacity battery charged to 68 percent capacity in two minutes and a 3,000 mAh battery charged to 48 percent capacity in five minutes. The latter battery has an energy density of 620 W·h/L. The device employed heteroatoms bonded to graphite molecules in the anode.

After wiping out a small German force about 50 km (31 mi) east of the Italian capital on 3 June, the 6th Division advanced north and captured the town of Paliano, then doubled back to the south-west and moved on Rome, which was reached on the morning of 6 June. A Squadron, Pretoria Regiment—that unit's squadron of Rhodesian tanks—entered the city as part of the division's vanguard. The German commander Albert Kesselring fought a stubborn delaying action, gradually withdrawing his armies north with three Allied columns in pursuit, the 6th Armoured Division leading the most westerly spearhead of the Eighth Army in the centre. The mountainous terrain and the effective use of anti-tank weapons by the retreating Germans made the Allies' superiority in armour less decisive and slowed the Allied advance north to the banks of the Arno between June and August 1944, during which time the Rhodesian tank squadrons took part in Allied victories at Castellana, Bagnoregio and Chiusi.

The PCR is prepared as usual (see PCR), and the reporter probe is added. As the reaction commences, during the annealing stage of the PCR both probe and primers anneal to the DNA target. Polymerisation of a new DNA strand is initiated from the primers, and once the polymerase reaches the probe, its 5'-3'-exonuclease degrades the probe, physically separating the fluorescent reporter from the quencher, resulting in an increase in fluorescence. Fluorescence is detected and measured in a real-time PCR machine, and its geometric increase corresponding to exponential increase of the product is used to determine the quantification cycle (Cq) in each reaction.

==== Associate of the Royal Red Cross (ARRC) ==== Flight Lieutenant Phillipa Jayne Ward (0409397), Princess Mary's Royal Air Force Nursing Service. Squadron Leader Hazel Weir (0409276), Princess Mary's Royal Air Force Nursing Service.

Sources: en.wikipedia.org

Frequently asked questions

How is peptide size measured in hydrolysate powders?

Peptide size is commonly estimated by size-exclusion chromatography, gel electrophoresis, or mass spectrometry. These techniques separate or identify molecules according to mass or hydrodynamic volume. Results depend on calibration and method conditions, so they are best compared within the same analytical protocol.

Why does hydrolysate powder clump during storage?

Clumping usually reflects moisture uptake by hygroscopic peptides and residual lactose. High humidity, temperature fluctuations, and damaged packaging can worsen caking. Sealed containers with desiccant and controlled storage reduce the problem.

Are hydrolysis measurements standardized across laboratories?

No universal reference method exists for all hydrolysates, although several established assays are used. Different methods measure different chemical features and can produce different numerical values. For this reason, specifications should state the assay and laboratory conditions.

What is whey protein hydrolysate?

It is whey protein that has been partially broken down into smaller peptides through hydrolysis. The powder still contains a mixture of peptides, residual protein, minerals, and other whey components. It is used as a food ingredient rather than a single pure compound.

Network